ATE365544T1 - Pharmazeutische zusammensetzungen enthaltend eine antihistaminische abschwellende arzneistoffkombination und ein verfahren zur herstellung davon - Google Patents
Pharmazeutische zusammensetzungen enthaltend eine antihistaminische abschwellende arzneistoffkombination und ein verfahren zur herstellung davonInfo
- Publication number
- ATE365544T1 ATE365544T1 AT02722540T AT02722540T ATE365544T1 AT E365544 T1 ATE365544 T1 AT E365544T1 AT 02722540 T AT02722540 T AT 02722540T AT 02722540 T AT02722540 T AT 02722540T AT E365544 T1 ATE365544 T1 AT E365544T1
- Authority
- AT
- Austria
- Prior art keywords
- pharmaceutical compositions
- deconstanting
- anthistaminic
- production
- compositions containing
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- 239000000890 drug combination Substances 0.000 title 1
- 239000000850 decongestant Substances 0.000 abstract 3
- RRJFVPUCXDGFJB-UHFFFAOYSA-N Fexofenadine hydrochloride Chemical compound Cl.C1=CC(C(C)(C(O)=O)C)=CC=C1C(O)CCCN1CCC(C(O)(C=2C=CC=CC=2)C=2C=CC=CC=2)CC1 RRJFVPUCXDGFJB-UHFFFAOYSA-N 0.000 abstract 1
- 230000001387 anti-histamine Effects 0.000 abstract 1
- 239000000739 antihistaminic agent Substances 0.000 abstract 1
- 229960003592 fexofenadine Drugs 0.000 abstract 1
- RWTNPBWLLIMQHL-UHFFFAOYSA-N fexofenadine Chemical compound C1=CC(C(C)(C(O)=O)C)=CC=C1C(O)CCCN1CCC(C(O)(C=2C=CC=CC=2)C=2C=CC=CC=2)CC1 RWTNPBWLLIMQHL-UHFFFAOYSA-N 0.000 abstract 1
- 229960000354 fexofenadine hydrochloride Drugs 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 239000007916 tablet composition Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
- A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/IB2002/001068 WO2003084510A1 (en) | 2002-04-04 | 2002-04-04 | Novel pharmaceutical compositions for antihistaminic-decongestant combination and method of making such compositions |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE365544T1 true ATE365544T1 (de) | 2007-07-15 |
Family
ID=28686908
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT02722540T ATE365544T1 (de) | 2002-04-04 | 2002-04-04 | Pharmazeutische zusammensetzungen enthaltend eine antihistaminische abschwellende arzneistoffkombination und ein verfahren zur herstellung davon |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US8263124B2 (de) |
| EP (1) | EP1490034B1 (de) |
| AT (1) | ATE365544T1 (de) |
| AU (1) | AU2002253425B2 (de) |
| CA (1) | CA2481377A1 (de) |
| DE (1) | DE60220953T2 (de) |
| WO (1) | WO2003084510A1 (de) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MXPA03009259A (es) * | 2001-04-09 | 2004-06-03 | Teva Pharma | Polimorfos de clorhidrato de fexofenadina. |
| WO2003104197A1 (en) | 2002-06-10 | 2003-12-18 | Teva Pharmaceutical Industries Ltd. | Polymorphic form xvi of fexofenadine hydrochloride |
| JP2007517766A (ja) * | 2003-09-24 | 2007-07-05 | コンビナトアールエックス インコーポレーティッド | 薬物の組み合わせを投与するための治療法 |
| US20080085311A1 (en) * | 2006-10-05 | 2008-04-10 | Tripathi Sanjay S | Antihistamine-decongestant combinations |
| WO2008114280A1 (en) * | 2007-03-21 | 2008-09-25 | Lupin Limited | Novel reduced dose pharmaceutical compositions of fexofenadine and pseudoephedrine |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3878217A (en) | 1972-01-28 | 1975-04-15 | Richardson Merrell Inc | Alpha-aryl-4-substituted piperidinoalkanol derivatives |
| US4996061A (en) | 1987-10-07 | 1991-02-26 | Merrell Dow Pharmaceuticals Inc. | Pharmaceutical composition for piperidinoalkanol-decongestant combination |
| EP0998272B1 (de) * | 1997-08-26 | 2003-05-02 | Aventis Pharmaceuticals Inc. | Arzneimittel für die kombination piperidinoalkanol-dekongestivum |
| ES2172944T3 (es) * | 1997-12-05 | 2002-10-01 | Alza Corp | Forma de dosificacion osmotica que comprende un primer y un segundo revestimiento. |
| US6267986B1 (en) * | 1999-09-24 | 2001-07-31 | Ranbaxy Laboratories Limited | Process for the preparation of a controlled drug delivery system containing pseudoephedrine and a long acting antihistamine |
| JP2003532671A (ja) | 2000-05-05 | 2003-11-05 | アベンティス・ファーマスーティカルズ・インコーポレイテツド | シュウドエフェドリン塩酸塩およびフェキソフェナジン塩酸塩の包装の規格化 |
| US6613906B1 (en) | 2000-06-06 | 2003-09-02 | Geneva Pharmaceuticals, Inc. | Crystal modification |
| MXPA03009259A (es) | 2001-04-09 | 2004-06-03 | Teva Pharma | Polimorfos de clorhidrato de fexofenadina. |
| US6627646B2 (en) * | 2001-07-17 | 2003-09-30 | Sepracor Inc. | Norastemizole polymorphs |
| WO2005102999A2 (en) * | 2004-04-26 | 2005-11-03 | Teva Pharmaceutical Industries Ltd. | Crystalline forms of fexofenadine hydrochloride and processes for their preparation |
-
2002
- 2002-04-04 CA CA002481377A patent/CA2481377A1/en not_active Abandoned
- 2002-04-04 US US10/510,064 patent/US8263124B2/en not_active Expired - Fee Related
- 2002-04-04 WO PCT/IB2002/001068 patent/WO2003084510A1/en not_active Ceased
- 2002-04-04 EP EP02722540A patent/EP1490034B1/de not_active Expired - Lifetime
- 2002-04-04 AT AT02722540T patent/ATE365544T1/de not_active IP Right Cessation
- 2002-04-04 AU AU2002253425A patent/AU2002253425B2/en not_active Ceased
- 2002-04-04 DE DE60220953T patent/DE60220953T2/de not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| WO2003084510A1 (en) | 2003-10-16 |
| US20060182800A1 (en) | 2006-08-17 |
| DE60220953T2 (de) | 2008-02-28 |
| DE60220953D1 (de) | 2007-08-09 |
| AU2002253425A1 (en) | 2003-10-20 |
| AU2002253425B2 (en) | 2008-09-25 |
| EP1490034A1 (de) | 2004-12-29 |
| EP1490034B1 (de) | 2007-06-27 |
| CA2481377A1 (en) | 2003-10-16 |
| US8263124B2 (en) | 2012-09-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1115484T1 (el) | Ενωσεις, συνθεσεις και μεθοδοι για την θεραπεια αμυλοειδικων ασθενειων και συνουκλεϊνοπαθειων, οπως νοσος alzheimer, διαβητης τυπου 2 και νοσος parkinson | |
| DE602005007339D1 (de) | Nebivolol und dessen pharmazeutisch unbedenkliche salze, herstellungsverfahren und pharmazeutische zusammensetzungen von nebivolol | |
| ATE397933T1 (de) | Kristallinform gamma-d von ivabradine- hydrochlorid, verfahren zu dessen herstellung und diesen enthaltende pharmazeutische zusammensetzung | |
| HUP0303876A3 (en) | Preparation of pharmaceutical compositions for treatment of type 2 diabetes using piperidine or tiazolidine, inhibitors of dipeptidyl peptidase iv | |
| ATE454138T1 (de) | Tablette mit modifizierter freisetzung von bupropion hydrochlorid | |
| DK1675591T3 (da) | Farmaceutisk sammensætning omfattende en monoamin-neurotransmitter-genoptagelseshæmmer og en acetylcholinesterase-hæmmer | |
| ATE397449T1 (de) | Kristallinform beta-d von ivabradine-hydrochlorid,verfahren zu dessen herstellung und diesen enthaltende pharmazeutische zusammensetzung | |
| NO20080827L (no) | Faste doseringsformuleringer av narkotiske legemidler som har forbedret bukal adsorpsjon | |
| BRPI0413393A (pt) | fexofenadina, composição farmaceuticamente aceitável, método de tratamento antihistamìnico, composição, processo para preparar fexofenadina e uso de fexofenadina | |
| DE60317803D1 (de) | Pharmazeutische zusammensetzungen enthaltend cyclosporin zur oralen verabreichung | |
| HUP0200438A3 (en) | Novel clopidogrel hydrochloride polymorphs, process for the preparation thereof, their use and pharmaceutical compositions containing them | |
| ATE367152T1 (de) | Herstellungsverfahren für niedrig dosierte pharmazeutische zusammensetzung | |
| NO20053119D0 (no) | Farmasoytiske sarmmensetninger med fentanyl for intranasal administrasjon. | |
| DE60304599D1 (de) | Pyridopyrimidinon-derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen | |
| EA200401515A1 (ru) | Новые фармацевтические композиции, содержащие флибансерин в полиморфной модификации а | |
| ATE358477T1 (de) | Oral anzuwendende arzneizusammensetzung enthaltend ein statinderivat | |
| DE602004024417D1 (de) | Neues verfahren zur herstellung von pleuromutilinderivaten | |
| DE60318167D1 (de) | Arzneiform und Verfahren zu ihrer Herstellung | |
| DE602005011326D1 (de) | Feste pharmazeutische zusammensetzung mit donepezilhydrochlorid | |
| IL164903A0 (en) | Processes for preparation of polymorphic form II of sertraline hydrochloride, pharmaceutical formulations and methods of administration thereof | |
| UA88481C2 (ru) | Донепезила фумарат, пригодный для получения фармацевтических композиций | |
| TW200606164A (en) | New compounds | |
| HUP0301082A2 (hu) | Új polimorf olanzapine hidroklorid sók, eljárás ezek előállítására, az ezeket tartalmazó gyógyászati készítmények és felhasználásuk | |
| ATE374172T1 (de) | Hexensäurederivate, verfahren zu deren herstellung, pharmazeutische zusammensetzungen, die diese enthalten, und therapeutische anwendungen davon | |
| DE60220953D1 (de) | Pharmazeutische zusammensetzungen enthaltend eine antihistaminische abschwellende arzneistoffkombination und ein verfahren zur herstellung davon |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |